Hikma Pharmaceuticals PLCShs Aktie
| 13,80EUR | -0,60EUR | -4,17% |
WKN: A0HG69 / ISIN: GB00B0LCW083
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 8 700 | 8 800 | 9 100 | 9 500 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,21 | 0,23 | 0,25 | 0,26 | 0,00 |
Bilanz (in Mio. GBP) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 546 | 1 662 | 1 647 | 1 807 | 1 965 |
| Summe Anlagevermögen | 1 682 | 2 055 | 2 024 | 2 292 | 2 251 |
| Summe Aktiva | 3 228 | 3 717 | 3 671 | 4 099 | 4 216 |
Bilanz (in Mio. GBP) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 406 | 1 931 | 1 938 | 2 245 | 2 279 |
| Summe Eigenkapital | 1 821 | 1 786 | 1 733 | 1 853 | 1 937 |
| Summe Passiva | 3 228 | 3 717 | 3 671 | 4 099 | 4 216 |
Adresse
| 1 New Burlington Place, W1S 2HR London | |
| Telefon | +44 (20) 7399-2760 |
| Fax | +44 (20) 7399-2761 |
| Internet | http://www.hikma.com |
Management
|
Areb Kurdi
Chief Financial Officer |
|
Bassam Wael Rushdi Kanaan
Executive Vice President-Corporate Development |
|
Cynthia L. Flowers
Independent Non-Executive Director |
|
Deneen Vojta
Independent Non-Executive Director |
|
Douglas Malcolm Hurt
Senior Independent Non-Executive Director |
|
Hafrun Fridriksdottir
President-USA Region |
|
Helen Middlemist
Group Secretary |
|
Hill Julie
SVP-Corporate Quality Compliance, Health & Safety |
|
Hussein Arkhagha
Chief People Officer |
|
Khalid Walid Hosni Nabilsi
Director |
|
Kristy Ronco
Executive VP-Sales & Marketing |
|
Laura Mihaela Balan
Independent Non-Executive Director |
|
Mary Regina Henderson
Independent Non-Executive Director |
|
Mazen Samih Taleb Darwazah
Executive Vice Chairman & Deputy CEO-MENA Region |
|
Mohammed Ali Khaldoun Al-Husry
Non-Executive Director |
|
Said Samih Taleb Darwazah
Chief Executive Officer & Director |
|
Susan Ringdal
Executive VP-Strategic Planning & Global Affairs |
|
Victoria Mary Hull
Chairman |
|
William C. Larkins
President-Injectables Business |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.